Please login to the form below

Not currently logged in
Email:
Password:

ProStrakan lines up new chairman for 2014

Dr John Brown will replace Peter Allen

ProStrakan Dr John BrownProStrakan's chairman Peter Allen has resigned from the company and will step down from the UK specialty pharmaceutical company's board at the end of the year.

He will be replaced by Dr John Brown, who is currently chairman of the government-backed Cell Therapy Catapult and Scottish contract research organisation CXR Biosciences.

Dr Brown also co-chairs the Scottish Government's Life Science Industry Advisory Board and was formerly chairman of BTG, Axis-Shield and, prior to that, chief executive of Acambis.

His appointment takes effect on January 1, 2014 after the departures of Peter Allen and non-executive Dr Michael Asbury, moves that ProStrakan said follow its own successful integration into its Japanese parent company Kyowa Hakko Kirin.

ProStrakan's chief executive Dr Tom Stratford said: "Peter and Mike have each been long-standing members of the ProStrakan board and, during their time with us, ProStrakan has grown significantly and transitioned from being a small independent company into an important part of Kyowa Hakko Kirin."

He added: "We are thrilled to have been able to attract someone with John's credentials as our new chairman. John brings with him a wealth of experience of the life sciences industry and we look forward to the guidance and advice that he will undoubtedly bring to the ProStrakan board.”

13th November 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics